GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HitGen Inc (SHSE:688222) » Definitions » EV-to-EBITDA

HitGen (SHSE:688222) EV-to-EBITDA : 55.52 (As of May. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is HitGen EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HitGen's enterprise value is ¥4,144.0 Mil. HitGen's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥74.6 Mil. Therefore, HitGen's EV-to-EBITDA for today is 55.52.

The historical rank and industry rank for HitGen's EV-to-EBITDA or its related term are showing as below:

SHSE:688222' s EV-to-EBITDA Range Over the Past 10 Years
Min: 54.07   Med: 165.02   Max: 468.45
Current: 55.84

During the past 8 years, the highest EV-to-EBITDA of HitGen was 468.45. The lowest was 54.07. And the median was 165.02.

SHSE:688222's EV-to-EBITDA is ranked worse than
87.56% of 450 companies
in the Biotechnology industry
Industry Median: 9.57 vs SHSE:688222: 55.84

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), HitGen's stock price is ¥12.28. HitGen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.149. Therefore, HitGen's PE Ratio for today is 82.42.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


HitGen EV-to-EBITDA Historical Data

The historical data trend for HitGen's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HitGen EV-to-EBITDA Chart

HitGen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - 141.09 80.54 71.60 56.60

HitGen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 380.80 185.54 163.46 56.60 61.54

Competitive Comparison of HitGen's EV-to-EBITDA

For the Biotechnology subindustry, HitGen's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HitGen's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HitGen's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HitGen's EV-to-EBITDA falls into.



HitGen EV-to-EBITDA Calculation

HitGen's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4144.027/74.639
=55.52

HitGen's current Enterprise Value is ¥4,144.0 Mil.
HitGen's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥74.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HitGen  (SHSE:688222) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HitGen's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12.28/0.149
=82.42

HitGen's share price for today is ¥12.28.
HitGen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.149.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


HitGen EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HitGen's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HitGen (SHSE:688222) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

HitGen (SHSE:688222) Headlines

No Headlines